Aging is associated with impaired T cell immune responses, raising the susceptibility of the elderly to infections and cancers. Aged T cells exhibit impaired T cell responses to T cell receptor (TCR) stimulation accompanied by reduced glycolytic activity, but the molecular basis of these defects is largely elusive. Using data-independent acquisition (DIA) mass spectrometry-based proteomic analysis, we identified pyruvate dehydrogenase kinase 1 (PDHK1), a key glycolytic enzyme, as significantly downregulated in aged murine T cells. This loss of PDHK1 expression was confirmed in both CD4 + and CD8 + T cells from aged mice, regardless of their naïve or activated state. Consistent with this, aged T cells exhibited defects in the activation of glycolysis immediately after TCR stimulation. Furthermore, CRISPR-mediated Pdhk1 deletion in young T cells led to defective activation and effector molecule expression upon TCR stimulation, whereas enforced PDHK1 expression in aged T cells facilitated these responses. These data suggest that aging diminishes PDHK1 expression in T cells, contributing to impaired glycolysis and T cell responses, which can be therapeutically restored by PDHK1 overexpression.
Kalra et al. (2026) studied this question.